1. Andriani A, Zullo A, Di Raimondo F, Patti C, Tedeschi L, Recine U, Caruso L, Bonanno G, Chiarenza A, Lizzani G et al: Clinical and endoscopic presentation of primary gastric lymphoma: a multicentre study. Alimentary pharmacology & therapeutics 2006, 23(6):721-726.
2. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014, 32(27):3059-3068.
3. Amin MBES., Greene FL, et al. AJCC cancer staging manual [M], 8th ed. Springer, New York. 2016.
4. Fléjou JF: [WHO Classification of digestive tumors: the fourth edition]. Annales de pathologie 2011, 31(5 Suppl):S27-31.
5. Ghimire P, Wu GY, Zhu L: Primary gastrointestinal lymphoma. World journal of gastroenterology 2011, 17(6):697-707.
6. Al-Akwaa AM, Siddiqui N, Al-Mofleh IA: Primary gastric lymphoma. World journal of gastroenterology 2004, 10(1):5-11.
7. Li XF, Fu Q, Dong YW, Liu JJ, Song XY, Dai D, Zuo C, Xu WG: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma. World journal of gastroenterology 2016, 22(34):7787-7796.
8. Fu L, Li H, Wang H, Xu B, Fan Y, Tian J: SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphoma. PloS one 2012, 7(12):e50914.
9. Yi JH, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS: 18F-FDG uptake and its clinical relevance in primary gastric lymphoma. Hematological oncology 2010, 28(2):57-61.
10. Alagöz E, Okuyucu K, İnce S, Kantarcıoğlu M, Özaydın Ş, Heper C, Türker T, Arslan N: Uptake Patterns of Untreated Primary Gastrointestinal Extranodal Lymphomas on Initial Staging (18)F-FDG PET/CT and Metabolic Tumor Parameters. Molecular imaging and radionuclide therapy 2017, 26(3):83-92.
11. Hwang JP, Lim I, Byun BH, Kim BI, Choi CW, Lim SM: Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma. Nuclear medicine communications 2016, 37(12):1267-1272.
12. Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, Fillet G: Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of oncology : official journal of the European Society for Medical Oncology 2001, 12(6):825-830.
13. Schöder H, Noy A, Gönen M, Weng L, Green D, Erdi YE, Larson SM, Yeung HW: Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005, 23(21):4643-4651.
14. Phongkitkarun S, Varavithya V, Kazama T, Faria SC, Mar MV, Podoloff DA, Macapinlac HA: Lymphomatous involvement of gastrointestinal tract: evaluation by positron emission tomography with (18)F-fluorodeoxyglucose. World journal of gastroenterology 2005, 11(46):7284-7289.
15. Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M et al: Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology 1994, 5(5):397-400.
16. Enomoto K, Hamada K, Inohara H, Higuchi I, Tomita Y, Kubo T, Hatazawa J: Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings. Annals of nuclear medicine 2008, 22(4):261-267.
17. Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, Naparstek E, Sapir EE, Polliack A: Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma. European journal of haematology 2007, 79(3):205-209.
18. Radan L, Fischer D, Bar-Shalom R, Dann EJ, Epelbaum R, Haim N, Gaitini D, Israel O: FDG avidity and PET/CT patterns in primary gastric lymphoma. European journal of nuclear medicine and molecular imaging 2008, 35(8):1424-1430.
19. Ambrosini V, Rubello D, Castellucci P, Nanni C, Farsad M, Zinzani P, Alavi A, Tehranipour N, Al-Nahhas A, Fanti S: Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. Nuclear medicine review Central & Eastern Europe 2006, 9(1):37-40.
20. Song KH, Yun M, Kim JH, Yang WI, Kang DR, Chung JB, Lee YC: Role of F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma. Gut and liver 2011, 5(3):308-314.
21. Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, Dhurairaj T, Dadparvar S, Alavi A: 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004, 45(11):1796-1803.
22. Tian J, Chen L, Wei B, Shao M, Ding Y, Yin D, Yao S: The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies. Nuclear medicine communications 2004, 25(8):825-831.
23. Nafteux PR, Lerut TE, Villeneuve PJ, Dhaenens JM, De Hertogh G, Moons J, Coosemans WJ, Van Veer HG, De Leyn PR: Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior. Annals of surgery 2014, 260(6):1023-1029.
24. Chon HJ, Hyung WJ, Kim C, Park S, Kim JH, Park CH, Ahn JB, Kim H, Chung HC, Rha SY et al: Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia. Annals of surgery 2017, 265(5):946-953.
25. Network CGAR: Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014, 513(7517):202-209.
26. Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT: Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdominal imaging 2009, 34(4):441-447.
27. Hopkins S, Yang GY: FDG PET imaging in the staging and management of gastric cancer. Journal of gastrointestinal oncology 2011, 2(1):39-44.
28. Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, Schwaiger M, Fink U: FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. European journal of nuclear medicine and molecular imaging 2003, 30(2):288-295.
29. Chon HJ, Kim C, Cho A, Kim YM, Jang SJ, Kim BO, Park CH, Hyung WJ, Ahn JB, Noh SH et al: The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2019, 22(1):113-122.
30. Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K: Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World journal of surgery 2004, 28(3):247-253.
31. Friedman J, Platnick J, Farruggia S, Khilko N, Mody K, Tyshkov M: Ménétrier disease. Radiographics : a review publication of the Radiological Society of North America, Inc 2009, 29(1):297-301.